About Syntr

Syntr Health Technologies, Inc is a start-up company that was founded by biomedical engineers and experienced surgeons. Together, they have developed and tested a microfluidic processing device, Syntrfuge™, for the microfragmentation of adipose tissue and its structural and supportive nature in the treatment of difficult-to-treat wounds, i.e. diabetic foot ulcers (DFU).

Syntr - Solution for Diabetic Foot Ulcer

July 11, 2016

Syntr Health Technology founded in Irvine, CA

October, 2015

Syntr Health Technologies undergraduate team was formed by Ahmed Zobi, Hugo Salas, Justin Stovner, and David Duarte

June, 2016

Core patent filed for the Syntrfuge System

Winner, UCI Applied Innovation Capstone Design Award & BioENGINE fellowship

February, 2017

Finalist, Tech Coast

Angels Fast Pitch

June, 2018

Patents pending

January, 2020

US patent granted

September, 2019

MVP completed

December, 2017

1st Place Winner, ICTS

Shark Tank Pitch Competition

November, 2019

South Korea patent granted

September, 2017

$300,000 grant from National Institutes of Health


Leadership Team

Ahmed Zobi


Chief Executive Officer

Hugo Salas


VP, Business Development

Justin Stovner


VP, Engineering


Scientific Advisors

Jered Haun, PhD

Professor UCI-BME

Alan Widgerow

CEO of Alastin Skincare

Business Advisors

Dane Shackleford

Former VP of

Spiracur Inc.

Ron King, PhD

Senior Director

Translational Programs,

UCI Applied Innovation

David Ochi


Regulatory Advisors

Deborah Madsen

Madsen QRC, LLC

Former Beckman Coulter

Regulatory Engineer

Fergie Ferguson

Sylmed Group Consultant Former MPS Medical Regulatory/QA Director

  • Facebook - White Circle
  • Twitter - White Circle
  • LinkedIn - White Circle

© Syntr Health Technologies, INC. 2020 All Rights Reserved.